Late Infection of an Atrial Septal Defect Closure Device: A Possible Complication

Thibodeau-Jarry, Nicolas; Ibrahim, Réda; Ducharme, Anique; Sia, Ying Tung

doi:10.1016/j.cjca.2015.01.043

Cited by 7 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We selected seven ASD device follow‐up studies , one meta‐analysis of percutaneous and surgical ASD closure , and two FDA databases . We identified twenty‐one cases of infective endocarditis following atrial septal device closure (Table ). Three studies did not meet the selection criteria (fungal endocarditis following ventricular septal defect hybrid procedure , atrial septal defect presenting with Brucella endocarditis , and patch abcess after surgical closure of an atrial septal defect ).…”

Section: Literature Reviewmentioning

confidence: 99%

Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature

Amedro

Soulatges

Fraisse

2016

Cathet Cardio Intervent

View full text Add to dashboard Cite

We report a case of late infective endocarditis in an 8-year-old boy 3 years after transcatheter closure of an atrial septal defect with the Amplatzer Atrial Septal Occluder Device. Echocardiography showed a very thick pannus lining the left atrial disc of the prosthesis, with some mobile elements. MRI showed several cerebral microemboli. The patient had dental caries and blood cultures found Staphylococcus aureus. Patient was treated with gentamicin and oxacillin before surgical removal of the prosthesis. Twenty-one cases of infective endocarditis after atrial defect device closure have been reported in the literature (13 ostium secundum ASD and 8 patent foramen ovale). Seven pediatric cases were reported. S. aureus was the most frequent bacterium. Antibiotics were administered in all cases and most patients (n = 18) underwent surgical removal of the device. Incomplete endothelialization of the prosthesis was a suggested mechanism. Two patients died after surgery. © 2016 Wiley Periodicals, Inc.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature

Amedro

Soulatges

Fraisse

2016

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…After extensive literature review, we found 23 reported cases of IE on ASD closure devices (Table 1 , Ref. [ 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 ]).…”

Section: Closure Devices and Shuntsmentioning

confidence: 99%

Emerging Concepts on Infection of Novel Cardiac Implantable Devices

Ramadan¹,

Gallo²,

Patauner³

et al. 2022

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Novel cardiac devices, including the MitraClip system, occluder devices, leadless pacemakers, and subcutaneous implantable cardioverter defibrillators (S-ICD), are mostly used in the management of patients who are at high risk for surgery and/or developing infections. Several mechanisms render most of these devices resistant to infection, including avoiding long transvenous access and novel manufacturing material. Since subjects who use these devices already endure several comorbid conditions, uncommon cases of device-associated infection could result in serious complications and increased mortality. In this review, we aim to summarize the current state of evidence on the incidence, clinical presentation, management, and prognosis of new cardiac devices' associated infection.

show abstract

“…При рассмотрении большинства из уже описанных клинических случаев невоз-можно точно определить, в какой момент произошла бактериальная инвазия. Часть исследователей не исключают роли незавер-шённой эндотелизации окклюдера, что де-лает его более уязвимым к бактериальной инвазии и тромбированию [11,13,14].…”

Section: а бunclassified

Surgical removal of atrial septal defect occlusion device and mitral valve replacement in a 39-year-old female patient with infective endocarditis

et al. 2018

View full text Add to dashboard Cite

РефератДефекты межпредсердной перегородки -вторые по частоте после дефектов межжелудочковой перегородки среди врождённых пороков сердца. Эндоваскулярное закрытие дефекта межпредсердной перегородки выпол-няют по строгим показаниям у пациентов со значимым сбросом крови слева направо. Развитие инфекционного эндокардита после транскатетерной имплантации окклюдера бывает чрезвычайно редким осложнением. В дан-ном клиническом наблюдении рассмотрен случай развития инфекционного эндокардита митрального клапана (с развитием выраженной недостаточности) через 13 лет после эндоваскулярного закрытия дефекта межпред-сердной перегородки у пациентки 39 лет. Перед выполнением хирургического вмешательства проведена ком-плексная антибиотикотерапия. В ходе операции выполнены удаление окклюдера дефекта межпредсердной пе-регородки, протезирование митрального клапана, пластика дефекта межпредсердной перегородки и резекция ушка левого предсердия. Послеоперационный период протекал без особенностей. Ключевые слова: окклюдер дефекта межпредсердной перегородки, инфекционный эндокардит, протезирова-ние митрального клапана, недостаточность митрального клапана. Surgical removal of atrial septal defect occlusion device and mitral valve replacement in a 39-year-old female patient with infective endocarditis A.S. Zotov, D.V. Borisov, T.V. Klypa, S.A. Vachev Federal Research Clinical Center for Specialized Types of Health Care and Medical Technologies of Federal Medical and Biology Agency, Moscow, RussiaAtrial septal defects represent the second most frequent congenital heart disease after ventricular septal defects. Transcatheter closure of an atrial septal defect is usually performed following strict indications on patients with significant left-to-right shunt. Infective endocarditis after transcatheter implantation of atrial septal defect occluder is an extremely rare complication. We report a case of infective endocarditis of the mitral valve (with severe mitral valve insufficiency) in a 39-year-old female patient 13 years after transcatheter closure of an atrial septal defect. Complex prophylactic antibiotic coverage was performed prior to surgical intervention. Surgical removal of atrial septal defect occluder, mitral valve replacement, atrial septal defect closure and left atrial appendage resection were performed. Postoperative course was uneventful. Keywords: atrial septal defect occluder, infective endocarditis, mitral valve replacement, mitral valve insufficiency.Адрес для переписки: dan-cer@inbox.ru Поступила 11.09.2017; принята в печать 03.10.2017.

show abstract

Late Infection of an Atrial Septal Defect Closure Device: A Possible Complication

Cited by 7 publications

References 6 publications

Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature

Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature

Emerging Concepts on Infection of Novel Cardiac Implantable Devices

Surgical removal of atrial septal defect occlusion device and mitral valve replacement in a 39-year-old female patient with infective endocarditis

Contact Info

Product

Resources

About